TransMedics Group Inc vs Vodafone Group Plc American Depositary Shares — how do they compare? TransMedics Group Inc trades at $77.87 (market cap $2.74B), while Vodafone Group Plc American Depositary Shares trades at $15.56 (market cap $38.08B). The key difference: Vodafone Group Plc American Depositary Shares is far larger — about 13.9× TransMedics Group Inc's market cap, and Vodafone Group Plc American Depositary Shares pays a 3.26% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and Vodafone Group Plc American Depositary Shares for 0 Days on average.
| TMDX | VOD | |
|---|---|---|
Market Cap | $2.74B | $38.08B |
Volume | 949,331 | 3,820,235 |
Sector | Health | Media |
52-Week High | $150.42 | $17.68 |
52-Week Low | $61.99 | $11.17 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $3.13B | $83.23B |
Dividend Yield | — | 3.26% |
Signals from Pluang's Aura AI — not financial advice
TMDX trades at $79.00, down 2.55% amid bearish technical signals. The stock shows strong profitability with 22.69% net margin and 36.28% ROE, though recent earnings misses and margin compression from 2025 to 2026 raise concerns. Analyst consensus remains bullish with a $99.75 price target, but multiple legal investigations into fiduciary duties create uncertainty. Revenue growth continues with 2026 guidance at $668M.
The stock presents a growth opportunity with analyst upside potential, but faces near-term headwinds from earnings volatility and legal scrutiny. Execution on 2026 guidance and resolution of governance concerns will be critical for sustained momentum. Current valuation at 20.47 P/E appears reasonable given growth prospects if operational targets are met.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →Vodafone provides mobile, fixed-line, broadband, and business communications services. It operates across Europe and Africa.
Read more on VOD →